Add to ORKG1 Development of gene expression based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitor
Purpose: Promoter hypermethylation of, for example, tumor-sup pressor genes, is considered to be an ...
DNA demethylating agents are approved for some blood malignancies and are under active investigation...
Ovarian cancer is the most lethal gynaecological cancer. Although having good response to chemothera...
1 Development of gene expression based score to predict sensitivity of multiple myeloma cells to DNA...
International audienceMultiple myeloma is a plasma cell cancer with poor survival, characterized by ...
Multiple myeloma is a plasma cell cancer with poor survival, characterized by the clonal expansion o...
International audienceBACKGROUND: Multiple myeloma (MM) is still a fatal plasma cell cancer. Novel c...
Multiple myeloma continues to be a lethal malignancy despite the development of treatments such as h...
International audienceHistone deacetylase inhibitors (HDACi) and DNA methyltransferase inhibitors (D...
Multiple myeloma (MM) is an incurable plasma cell neoplasm. Pathogenesis involves upregulation of D-...
Outcome in multiple myeloma is highly variable and a better understanding of the factors that influe...
International audienceBACKGROUND: Multiple myeloma (MM) is a malignant plasma cell disease with a po...
Background In today's practice, gene-based approaches come to the fore in the determination of progn...
International audienceMultiple myeloma (MM) is a malignancy characterized by accumulation of maligna...
Aberrant methylation of tumor suppressor genes (TSG) is an important epigenetic event in cancer, inc...
Purpose: Promoter hypermethylation of, for example, tumor-sup pressor genes, is considered to be an ...
DNA demethylating agents are approved for some blood malignancies and are under active investigation...
Ovarian cancer is the most lethal gynaecological cancer. Although having good response to chemothera...
1 Development of gene expression based score to predict sensitivity of multiple myeloma cells to DNA...
International audienceMultiple myeloma is a plasma cell cancer with poor survival, characterized by ...
Multiple myeloma is a plasma cell cancer with poor survival, characterized by the clonal expansion o...
International audienceBACKGROUND: Multiple myeloma (MM) is still a fatal plasma cell cancer. Novel c...
Multiple myeloma continues to be a lethal malignancy despite the development of treatments such as h...
International audienceHistone deacetylase inhibitors (HDACi) and DNA methyltransferase inhibitors (D...
Multiple myeloma (MM) is an incurable plasma cell neoplasm. Pathogenesis involves upregulation of D-...
Outcome in multiple myeloma is highly variable and a better understanding of the factors that influe...
International audienceBACKGROUND: Multiple myeloma (MM) is a malignant plasma cell disease with a po...
Background In today's practice, gene-based approaches come to the fore in the determination of progn...
International audienceMultiple myeloma (MM) is a malignancy characterized by accumulation of maligna...
Aberrant methylation of tumor suppressor genes (TSG) is an important epigenetic event in cancer, inc...
Purpose: Promoter hypermethylation of, for example, tumor-sup pressor genes, is considered to be an ...
DNA demethylating agents are approved for some blood malignancies and are under active investigation...
Ovarian cancer is the most lethal gynaecological cancer. Although having good response to chemothera...